AVLAR BIOVENTURES
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
AVLAR BIOVENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 (0) 1954 211 515
Email Addresses:
[email protected]
Technology used in webpage:
Common Name Invalid British Server Location Zen Internet
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2010-01-20 | Crescendo Biologics | Avlar BioVentures investment in Series A - Crescendo Biologics | 7.3 M USD |
| 2009-10-12 | Crescendo Biologics | Avlar BioVentures investment in Seed Round - Crescendo Biologics | 4.5 M GBP |
| 2006-07-18 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 1.2 M GBP |
| 2006-07-07 | Takeda Cambridge | Avlar BioVentures investment in Series D - Takeda Cambridge | 12.96 M USD |
| 2006-01-01 | NXVISION | Avlar BioVentures investment in Venture Round - NXVISION | 688 K USD |
| 2005-08-01 | Intercytex Group | Avlar BioVentures investment in Series D - Intercytex Group | 12 M GBP |
| 2005-05-01 | Amura | Avlar BioVentures investment in Venture Round - Amura | 1.84 M USD |
| 2005-04-07 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 250 K GBP |
| 2005-01-07 | Takeda Cambridge | Avlar BioVentures investment in Venture Round - Takeda Cambridge | 9.38 M USD |
| 2004-12-01 | Purely Proteins Limited | Avlar BioVentures investment in Series B - Purely Proteins Limited | 3.6 M USD |
More informations about "Avlar BioVentures"
Avlar BioVentures
Avlar BioVentures Founded by Alan Goodman and Daniel Roach, Avlar manages two funds: Avlar Fund II and the First Cambridge Gateway Fund, which together total approximately £78 …See details»
Avlar BioVentures investment portfolio - PitchBook
Avlar BioVentures's latest investment was on 05-Oct-2012 in Crescendo Biologics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Avlar BioVentures - CB Insights
Jan 2, 2000 Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures Fund II and the …See details»
Avlar Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Avlar Ltd including stock price, company news, executives, board members, and contact information. ... Avlar Bioventures serves clients in the United Kingdom. ...See details»
Avlar BioVentures - Funding, Financials, Valuation & Investors
Avlar BioVentures has raised 2 funds, their latest being AVLAR BIOVENTURES FUND II. Announced Date . Fund Name . Money Raised . Sep 1, 2001: AVLAR BIOVENTURES FUND …See details»
Avlar BioVentures
Avlar BioVentures Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in …See details»
Avlar Bioventures - Investor Profile, Portfolio & Team - Tracxn
Avlar Bioventures - VC firm focused on early stage investments in bioscience industry. Portfolio of 8 companies. 14 investors have invested with Avlar Bioventures. Team has 2 partners.See details»
Avlar BioVentures - Investments, Portfolio & Company Exits
Avlar BioVentures has had . obfuscated. obfuscated. exit, which was NXVISION. Which industries has this organization had the most exits in? Show . NXVISION NXVISION is a web platform …See details»
Avlar BioVentures - Golden
Avlar BioVentures was a Cambridge based venture capital firm focused on investments in biopharmaceutical, small molecule drug discovery, epigenetics, medical technology and …See details»
Avlar BioVentures | Institution Profile | Private Equity International
Avlar BioVentures. News, insights, analysis and data. Avlar BioVentures overview. Incorporated in 1998, Avlar BioVentures was a Cambridge-based private equity firm, targeting early-stage …See details»
Cambridge Venture Partners - University of Cambridge
Jun 6, 2005 The new entity, to be known as Cambridge Venture Partners, comprises the Challenge Fund together with the 3i Group, Amadeus Capital Partners, Avlar BioVentures, …See details»
Avlar BioVentures Fund I: Performance - PitchBook
May 1, 2001 Avlar BioVentures Fund I's latest investment was on 09-Dec-2002 in Paradigm Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our …See details»
Avlar BioVentures Fund II: Performance - PitchBook
Avlar BioVentures Fund II was a venture capital fund managed by Avlar BioVentures. The fund was located in Cambridge, United Kingdom. The fund targeted pharmaceuticals and …See details»
Alan Goodman - Owner - Avlar Bioventures | LinkedIn
Owner, Avlar Bioventures · Experience: Avlar Bioventures · Location: Greater Cambridge Area · 500+ connections on LinkedIn. View Alan Goodman’s profile on LinkedIn, a professional …See details»
Avlar BioVentures — 15 Deals, 8 Portfolio startups, Statistics ...
Avlar BioVentures is the famous VC, which was founded in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the …See details»
Avlar BioVentures - Updates, News, Events, Signals & Triggers
Avlar BioVentures is a venture capital firm that offers seed- and early-stage investments.See details»
Alan G. Goodman - Crunchbase Person Profile
Mr. Alan G. Goodman serves as the Chief Executive Officer and Chief Financial Officer at Avlar BioVentures Ltd. Mr. Goodman has over 20 years experience in the biotechnology and …See details»
Daniel Roach - Crunchbase Person Profile
Dr. Daniel Roach, Ph.D serves as an Investment Director of Avlar BioVentures Ltd. Dr. Roach serves as an Investment Director of the ATM group of companies, Purely Proteins, and …See details»